Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030
... and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030 Global Generic Pharmaceuticals Market is valued ... Read More
-
Metal Stamping Global Market Opportunities And Strategies To 2032
... need to assess the global metal stamping market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
-
Pharmaceutical Contract Manufacturing Market by Service (Pharmaceutical (API, FDF - Tablet, Capsule, Injectable)), Biologic (API, FDF), Drug Development), End User (Big Pharma, Small & Medium-sized Pharma, Generic Pharma) - Global Forecast to 2028
... pharmaceutical contract development and manufacturing market size is projected to reach USD 258.3 billion by 2028 from USD 176.5 billion in 2023, at a CAGR of 7.9% during the forecast period. Factors such as increasing ... Read More
-
United States Pharmaceutical Logistics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... Highlights Transportation problems were making it hard to distribute COVID-19, which was causing problems in the drug supply chain.Port disruptions, quarantined personnel, and labor shortages caused by lockdowns were all factors. Furthermore, COVID-19 slowed the ... Read More
-
United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
... grow at a CAGR of 6.39% from 2022 to 2028. The pharmaceutical industry is vital for global healthcare, but it is important to distinguish between factors driving cost increases and those generating savings. Specialty drugs, ... Read More
-
US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 110.7 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028. Generics are off-patented drugs that are bioequivalent to branded medications in terms of dosage, strength, quality, form, effect, intended use, side effects, ... Read More
-
Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 460.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.83% during 2023-2028. Generic drugs are bioequivalent of branded medicines with the same active ingredients and equivalent therapeutic effects. They also have similar dosages, risks, ... Read More
-
Impact of South Korea on the Pharmaceutical Industry - Thematic Intelligence
... South Korea is a market that offers significant potential for big pharma manufacturing, with domestic companies dominating the marketed product landscape as encouraged by government policy. The top three therapy areas among marketed and pipeline ... Read More
-
Finasteride Market By Application (Benign Prostatic Hyperplasia (BPH), Male pattern baldness), By Type (Branded , Generic), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... The finasteride market valued for $362.11 million in 2021 and is estimated to reach $546.72 million by 2031, exhibiting a CAGR of 4.2% from 2022 to 2031. Finasteride is a medication used primarily for the ... Read More
-
Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The Middle East & Africa pulmonary arterial hypertension market is expected to grow from ... Read More
-
North America Pulmonary Arterial Hypertension Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The North America pulmonary arterial hypertension market is expected to grow from US$ 3,147.76 million in ... Read More
-
South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/ subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... and Generics), Route of Administration (Oral, Intravenous/ subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The South & Central America pulmonary arterial hypertension market is expected to grow ... Read More
-
Europe Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The Europe pulmonary arterial hypertension market is expected to grow from US$ 1,959.47 million in 2022 to US$ ... Read More
-
Asia Pacific Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The Asia Pacific pulmonary arterial hypertension market is expected to grow from US$ 1,531.47 million in 2022 ... Read More
-
Generic Pharmaceuticals Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics, Biosimilars), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region And Segment Forecasts, 2023 - 2030
... Generic Pharmaceuticals Market Growth & Trends The global generic pharmaceuticals market is expected to reach over USD 682.9 billion expanding at a CAGR of 8.3% from 2023 to 2030, according to a new study by ... Read More
-
South America Malaria Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)
... & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others) The SAM malaria treatment market is expected to grow from US$ 71.79 ... Read More
-
Middle East & Africa Malaria Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)
... and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others) The MEA malaria treatment market is expected to grow from ... Read More
-
Active Pharmaceutical Ingredients (Api) Market- Growth, Trends, Covid-19 and Forecasts (2023 - 2028)
... 258.60 billion by 2027, registering a CAGR of nearly 7.50% during the forecast period 2022-2027. In 2020, the COVID-19 outbreak had a favorable impact on the market as the countries and major players are manufacturing ... Read More
-
Zimbabwe Pharmaceutical Market - Growth, Trends, Covid-19 Impact and Forecast (2023 - 2028)
... industry in Zimbabwe was significant. The industry saw an increased demand for therapeutics to treat COVID-19-infected patients, which further led to an increase in the large-scale manufacturing of pharmaceutical products in the country. As the ... Read More
-
Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 30.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.76% during 2023-2028. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after ... Read More
-
Global Generic Injectable Drugs Market Growth (Status and Outlook) 2023-2029
... that are prepared into solutions or suspensions before use. The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. ... Read More
-
Global Generic Injectables Market Growth (Status and Outlook) 2023-2029
... prepared into solutions or suspensions before use. The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is ... Read More
-
Global Generic Drugs Market Growth (Status and Outlook) 2023-2029
... term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold. LPI (LP ... Read More
-
Global Inhalation & Nasal Spray Generic Drugs Market Growth 2023-2029
... dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Inhalation & Nasal Spray is a ... Read More
-
Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The pulmonary arterial hypertension market is expected to grow from US$ 7,369.89 million in 2021 to US$ 10,889.08 million ... Read More
Research Assistance
